Fighting Cancer with Off-the-Shelf iPSC Immunotherapies
In June 2016 we hosted an educational session at the International Society for Stem Cell Research (ISSCR) annual conference titled, “Fighting Cancer with Off-the-Shelf iPSC Immunotherapies”. This conference is widely regarded as the preeminent meeting for the latest scientific advances and therapeutic breakthroughs in stem cell therapy research and development. The session included presentations from globally-recognized leaders in the fields of iPSCs and cellular immunotherapies and included a comprehensive overview of Fate’s development of genetically engineered, off-the-shelf, iPSC-derived NK- and T-cell immunotherapies for the treatment of cancer.
Provided below is a summary of these sessions, along with links to each of the presentations: